Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. 8-K Event Results of operations
  2. ARS Other Annual Report to Security Holders
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. 4 Insider Changes in Ownership
  6. 144 Insider Sale of Securities
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. 144 Insider Sale of Securities
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 4 Insider Changes in Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 2 of 21 · 403 filings